Literature DB >> 26775899

Morphological diversity of Paramoeba perurans trophozoites and their interaction with Atlantic salmon, Salmo salar L., gills.

J Wiik-Nielsen1, T A Mo1, H Kolstad2, S N Mohammad1, S Hytterød1, M D Powell3.   

Abstract

Amoebic gill disease (AGD) caused by the ectoparasite Paramoeba perurans affects several cultured marine fish species worldwide. In this study, the morphology and ultrastructure of P. perurans in vitro and in vivo was investigated using scanning and transmission electron microscopy (SEM and TEM, respectively). Amoebae cultures contained several different morphologies ranging from a distinct rounded cell structure and polymorphic cells with pseudopodia of different lengths and shapes. SEM studies of the gills of AGD-affected Atlantic salmon, Salmo salar L., revealed the presence of enlarged swellings in affected gill filaments and fusion of adjacent lamellae. Spherical amoebae appeared to embed within the epithelium, and subsequently leave hemispherical indentations with visible fenestrations in the basolateral surface following their departure. These fenestrated structures corresponded to the presence of pseudopodia which could be seen by TEM to penetrate into the epithelium. The membrane-membrane interface contained an amorphous and slightly fibrous matrix. This suggests the existence of cellular glycocalyces and a role for extracellular products in mediating pathological changes in amoebic gill disease.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  amoebic gill disease; gill epithelium; glycocalyx; pseudopodia; scanning electron microscopy

Mesh:

Year:  2016        PMID: 26775899     DOI: 10.1111/jfd.12444

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  8 in total

1.  Evaluation of Low Temperature and Salinity as a Treatment of Atlantic Salmon against Amoebic Gill Disease.

Authors:  Jemma Hudson; Mark Adams; Khattapan Jantawongsri; Tim Dempster; Barbara F Nowak
Journal:  Microorganisms       Date:  2022-01-18

2.  Effect of repeated exposure to AQUI-S® on the viability and growth of Neoparamoeba perurans.

Authors:  R J Chance; Z Allcock; C J Secombes; B Collet; C Collins
Journal:  J Fish Dis       Date:  2017-09-25       Impact factor: 2.767

3.  Effects of cnidarian biofouling on salmon gill health and development of amoebic gill disease.

Authors:  Nina Bloecher; Mark Powell; Sigurd Hytterød; Mona Gjessing; Jannicke Wiik-Nielsen; Saima N Mohammad; Joachim Johansen; Haakon Hansen; Oliver Floerl; Anne-Gerd Gjevre
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

4.  Comparative transcriptome profiling of virulent and avirulent isolates of Neoparamoeba perurans.

Authors:  Aaron J Smith; Philip B B Crosbie; Barbara F Nowak; Andrew R Bridle
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

5.  Sea lice (Lepeophtherius salmonis) detection and quantification around aquaculture installations using environmental DNA.

Authors:  Adriana Krolicka; Mari Mæland Nilsen; Brian Klitgaard Hansen; Magnus Wulf Jacobsen; Fiona Provan; Thierry Baussant
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

6.  The Effect of Antimicrobial Treatment upon the Gill Bacteriome of Atlantic Salmon (Salmo salar L.) and Progression of Amoebic Gill Disease (AGD) In Vivo.

Authors:  Joel Slinger; Mark B Adams; Chris N Stratford; Megan Rigby; James W Wynne
Journal:  Microorganisms       Date:  2021-05-02

7.  Revision of Coelastrella (Scenedesmaceae, Chlorophyta) and first register of this green coccoid microalga for continental Norway.

Authors:  F Goecke; J Noda; M Paliocha; H R Gislerød
Journal:  World J Microbiol Biotechnol       Date:  2020-09-11       Impact factor: 3.312

8.  In vitro gill cell monolayer successfully reproduces in vivo Atlantic salmon host responses to Neoparamoeba perurans infection.

Authors:  Irene Cano; Nick Gh Taylor; Amanda Bayley; Susie Gunning; Robin McCullough; Kelly Bateman; Barbara F Nowak; Richard K Paley
Journal:  Fish Shellfish Immunol       Date:  2018-11-17       Impact factor: 4.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.